Monday, May 08, 2017 9:03:13 AM
Focalin was different because they were told they had to redo the Bioequvilance data. A update on that could've been given I agree. But this isn't that scenario. For whatever reason the FDA jumped the gun and posted the "approvals" with out giving ipci their approval letters. If you want someone to tell you they haven't gotten an approval yet call and ask. I'm sure he will tell you they haven't been informed of an approval by the FDA.
We all know it should be coming any day now. It's been 5 business days. If it doesn't come in the near future and they receive some communication from the FDA as per a reason WHY, then maybe there is cause to issue a PR and inform shareholders. But as of now its business as usual until the FDA advises them of anything good or bad.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM